Source: Stem Cells International. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, MEDULA ÓSSEA, RETINA, ACUIDADE VISUAL
ABNT
COTRIM, Carina Costa et al. Intravitreal use of a Bone Marrow Mononuclear Fraction (BMMF) containing CD34+ cells in patients with Stargardt type macular dystrophy. Stem Cells International, v. 2020, p. 1-8, 2020Tradução . . Disponível em: https://doi.org/10.1155/2020/8828256. Acesso em: 12 out. 2024.APA
Cotrim, C. C., Messias, A. M. V., Jorge, R., & Siqueira, R. C. (2020). Intravitreal use of a Bone Marrow Mononuclear Fraction (BMMF) containing CD34+ cells in patients with Stargardt type macular dystrophy. Stem Cells International, 2020, 1-8. doi:10.1155/2020/8828256NLM
Cotrim CC, Messias AMV, Jorge R, Siqueira RC. Intravitreal use of a Bone Marrow Mononuclear Fraction (BMMF) containing CD34+ cells in patients with Stargardt type macular dystrophy [Internet]. Stem Cells International. 2020 ; 2020 1-8.[citado 2024 out. 12 ] Available from: https://doi.org/10.1155/2020/8828256Vancouver
Cotrim CC, Messias AMV, Jorge R, Siqueira RC. Intravitreal use of a Bone Marrow Mononuclear Fraction (BMMF) containing CD34+ cells in patients with Stargardt type macular dystrophy [Internet]. Stem Cells International. 2020 ; 2020 1-8.[citado 2024 out. 12 ] Available from: https://doi.org/10.1155/2020/8828256